Erik Welf
Critic · DISC type CErik Welf serves as the Director and Head of Integrative Systems Biology at Orion Pharma. Leveraging his PhD from the University of Delaware, he specializes in experimental biology and quantitative pharmacology, designing strategies to move drug assets from ideation to approval more efficiently.
His research has uncovered that the "blebs" on highly metastatic cancer cells are not just for movement but also function as critical signaling hubs that promote cell survival.
Read the full overview →How Erik shows up
They like to do things independently and don’t look for support from others. Unless the value is proven by data, they are unlikely to value fancy features. It is very likely that they will negotiate pricing or other important terms.
Topics Erik cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.